Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis

Pasquale Bernardo1, Maria Letizia Conforti, Silvia Bellando-Randone

  • 1Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.

Insights

Implantable cardioverter-defibrillators (ICDs) can prevent sudden cardiac death in patients with systemic sclerosis (SSc) who experience ventricular arrhythmias. This study shows ICDs effectively managed dangerous heart rhythms in SSc patients.

Area of Science:

  • Cardiology
  • Rheumatology
  • Medical Devices

Background:

  • Cardiac involvement in systemic sclerosis (SSc) is associated with a poor prognosis.
  • Conduction defects and arrhythmias are common in SSc patients, increasing the risk of sudden cardiac death.

Purpose of the Study:

  • To evaluate the efficacy of electrophysiologic studies and implantable cardioverter-defibrillators (ICDs) in managing ventricular arrhythmias in SSc patients.
  • To determine if ICD implantation can prevent sudden cardiac death in this high-risk population.

Main Methods:

  • Implantable cardioverter-defibrillators (ICDs) were implanted in 10 patients diagnosed with systemic sclerosis (SSc) and confirmed cardiac involvement.
  • Device data was analyzed over a 36-month follow-up period.

Main Results:

  • Three out of 10 patients experienced episodes of ventricular tachycardia during the follow-up period.
  • The implanted ICDs successfully detected and reverted these episodes of ventricular tachycardia via electrical shock delivery.

Conclusions:

  • Implantation of an implantable cardioverter-defibrillator (ICD) may be a recommended intervention for patients with systemic sclerosis (SSc) presenting with ventricular arrhythmias.
  • ICDs demonstrate potential in preventing sudden cardiac death in SSc patients with significant cardiac involvement and arrhythmias.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...